GlassScriptPhysician profile
Tammy Birbeck
NPI 1316939416
$7,290.71
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,057 · 2020: $3,676 · 2021: $273 · 2022: $89.13 · 2023: $69.54 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,550.41 | 2019-2024 | |
| Abbvie INC. | $262.19 | 2019-2022 | |
| Hologic Sales and Service, LLC | $113.74 | 2019-2021 | |
| Pfizer INC. | $96.14 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $41.27 | 2023-2024 | Gemtesa |
| Allergan, INC. | $40.86 | 2020-2021 | |
| Therapeuticsmd, INC. | $39.56 | 2019 | |
| Axonics, INC. | $28.86 | 2023 | Axonics, Bulkamid |
| Amag Pharmaceuticals, INC. | $20.83 | 2019 | |
| Exeltis, USA INC. | $18.29 | 2021 | |
| Duchesnay USA Incorporated | $17.93 | 2019 | |
| Becton, Dickinson and Company | $17.05 | 2022 | |
| Aspira Women'S Health INC | $16.98 | 2019 | |
| 180 Medical, INC. | $15.47 | 2019 | |
| Amgen INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Birbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.